Genetics in obstetricians' offices: A survey study

Obstetrics and Gynecology

Volumn 93, Issue 5, 1999, Pages 642-647

  WILKINS HAUG, LOUISE ^a   HILL, LAUREN ^a   SCHMIDT, LOUIS ^b   Holzman, Gerald B ^c   Schulkin, JAY ^c  

^a AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; ARTICLE; GENETIC DISORDER; HUMAN; MEDICAL INFORMATION; MEDICAL PRACTICE; NEURAL TUBE DEFECT; NORMAL HUMAN; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SCIENCE;

ABNORMALITIES; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; INFANT, NEWBORN; MALE; MIDDLE AGED; OBSTETRICS; PHYSICIAN-PATIENT RELATIONS; PREGNANCY; PRENATAL CARE; RISK ASSESSMENT;

EID: 0032925625     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1016/S0029-7844(98)00529-8     Document Type: Article

References (13)

1. Genetic testing for cystic fibrosis. National Institutes of Health Consensus Statement 1997 Apr 14-16;15(4):1-37.
2. Asch DA, Hershey JC, Dekay ML, Pauly MV, Patton JP, Jedrziewski MK, et al. Carrier screening for cystic fibrosis: Costs and clinical outcomes. Med Decis Making 1998;18:202-12.
3. Asch DA, Hershey JC, Pauly MV, Patton JP, Jedrziewski MK, Mennuti MT. Genetic screening for reproductive planning: Methodological and conceptual issues in policy analysis. Am J Public Health 1996;86:684-90.
4. Asch DA, Patton JP, Hershey JC, Mennuti MT. Reporting the results of cystic fibrosis carrier screening. Am J Obstet Gynecol 1993;168:1-6.
5. Grody W, Dunkel-Schetter C, Tatsugawa ZH, Fox MA, Fang CY, Cantor RM, et al. PCR-based screening for cystic fibrosis carrier mutations in an ethnically diverse pregnant population. Am J Hum Genet 1997;60:935-47.
6. American College of Obstetricians and Gynecologists. Genetic screening for hemoglobinopathies. ACOG committee opinion no. 168. Washington, DC: American College of Obstetricians and Gynecologists, 1996.
7. American College of Obstetricians and Gynecologists. Screening for Tay-Sachs disease. ACOG committee opinion no. 162. Washington, DC: American College of Obstetricians and Gynecologists, 1995.
8. American College of Obstetricians and Gynecologists. Fragile X syndrome. ACOG committee opinion no. 161. Washington, DC: American College of Obstetricians and Gynecologists, 1995.
9. American College of Medical Genetics. Position statement on carrier testing for Canavan disease. Bethesda, Maryland: American College of Medical Genetics, 1998.
10. Giardiello FM, Brensinger JD, Petersen GM, Luce MC, Hylind LM, Bacon JA, et al. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med 1997;336:823-7.
11. American College of Medical Genetics statement. Professional disclosure of familial genetic information. The American College of Human Genetics Social Issues Subcommittee on Familial Disclosure. Am J Hum Genet 1998;62:474-83.
12. Touchette N, Holtzman NA, Davis JG, Feetham S. Toward the 21st century: Incorporating genetics into primary health care. Plainview, New York: Cold Spring Harbor Laboratory Press, 1997.
13. Bernhardt BA, Geller G, Doksum T, Larson SM, Roter D, Holtzman NA. Prenatal genetic testing: Content of discussions between obstetric providers and pregnant women. Obstet Gynecol 1998;91:648-55.